NVG:NYE-Nuveen Enhanced AMT-Free Municipal Credit Opportunities Fund of Beneficial Interest (USD)

ETF | Medical Distribution | New York Stock Exchange

Last Closing

USD 12.06

Change

+0.09 (+0.75)%

Market Cap

USD 2.84B

Volume

0.45M

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Nuveen Enhanced AMT-Free Municipal Credit Opportunities Fund is a closed-end investment company. Its investment objective is to provide attractive level of total return, through long-term capital appreciation and secondarily through income and gains.

Inception Date: 25/03/2002

Primary Benchmark: BBgBarc Municipal Insured TR USD

Primary Index: BBgBarc Municipal TR USD

Gross Expense Ratio: 1.5%

Management Expense Ratio:

Unadjusted Closing Price

Adjusted Closing Price

Assets

N/A

Top Holdings

N/A

Top Sectors

N/A

Top Regions

N/A

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-03-27 )

Largest Industry Peers for Medical Distribution

Symbol Name Mer Price(Change) Market Cap
MCK McKesson Corporation 0.00 %

N/A

USD 70.80B
COR Cencora Inc. 0.00 %

N/A

USD 38.52B
CAH Cardinal Health Inc 0.00 %

N/A

USD 26.32B
OMI Owens & Minor Inc 0.00 %

N/A

USD 2.06B

ETFs Containing NVG

MFLX First Trust Flexible Muni.. 0.45 % 0.00 %

N/A

USD 0.02B
PGAL 0.00 % 0.57 %

N/A

N/A
MCEF 0.00 % 0.75 %

N/A

N/A
XMPT 0.00 % 0.40 %

N/A

N/A
CD47:XETRA 0.00 % 0.00 %

N/A

N/A

Market Performance

  Market Performance vs. Industry/Classification (Medical Distribution) Market Performance vs. Exchange (New York Stock Exchange)
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 2.03% 20% F 45% F
Dividend Return 1.34% 100% F 65% D
Total Return 3.37% 20% F 47% F
Trailing 12 Months  
Capital Gain 4.69% 20% F 42% F
Dividend Return 4.03% 100% F 58% F
Total Return 8.72% 20% F 41% F
Trailing 5 Years  
Capital Gain -20.19% 20% F 24% F
Dividend Return 23.81% 100% F 79% B-
Total Return 3.62% 20% F 31% F
Average Annual (5 Year Horizon)  
Capital Gain -7.20% 20% F 14% F
Dividend Return -2.43% 20% F 18% F
Total Return 4.77% 100% F 81% B-
Risk Return Profile  
Volatility (Standard Deviation) 14.79% 80% B- 69% C-
Risk Adjusted Return -16.39% 20% F 19% F
Market Capitalization 2.84B 20% F 2% F

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Underpriced compared to earnings

The stock is trading low compared to its peers on a price to earning basis and is in the top quartile. It may be underpriced but do check its financial performance to make sure there is no specific reason.

Superior total returns

The stock has outperformed its sector peers on average annual total returns basis in the past 5 years (for a hold period of at least 12 months) and is in the top quartile.

Low volatility

The stock’s annual returns have been stable and consistent compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile. Although stability is good, also keep in mind it can limit returns.

What to not like:
Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.

Below median dividend returns

The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.

Low market capitalization

This is among the smaller entities in its sectors with below median market capitalization. That may make it less stable in the long run unless it has a unique technology or market which can help it grow or get acquired in future.

Negative free cash flow

The company had negative total free cash flow in the most recent four quarters.